Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wabeso Enhanced Enzymatics, Inc.
Los Osos, California, United Stateswabeso.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
No direct clinical trial data publicly available. The company holds multiple US patents related to their enzymatic compositions demonstrating potential efficacy in reducing inflammation markers and viral/bacterial agents at a biochemical level. Their patented enzymes reportedly degrade key inflammatory mediators without harming cell viability[5][4].
- Therapeutic areas
- DermatologyInfectious DiseasesRheumatology
- Modalities
- Enzyme-based therapeutics and productsProtease enzymes derived from fish sources such as cod trypsin and chymotrypsinSelf-sterilizing fabrics with cold-active proteases for antiviral applications
- Industry
- Biotech
Beyond the preview
Go deeper on Wabeso Enhanced Enzymatics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wabeso Enhanced Enzymatics, Inc..